Heidelberg Innovation PresseHeidelberg Innovation - einer der führenden deutschen Venture-Capital-Gesellschaften im Bereich der Life Sciences
http://www.hd-innovation.com/en/presse/
Biofrontera and Desitin sign marketing and distribution agreement for Ameluz® in Scandinavia
http://www.hd-innovation.com/en/presse/?id=660
2012-02-06Biofrontera AG - 500,000 shares subscribed in capital increase
http://www.hd-innovation.com/en/presse/?id=659
2012-02-03Biofronterra's Ameluz® as of today available in all Geman pharmacies
http://www.hd-innovation.com/en/presse/?id=658
2012-02-01Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement
http://www.hd-innovation.com/en/presse/?id=653
2012-01-24Pressure BioScience, Inc. Announces Global Co-Marketing/Selling and Instrument Co-Development Agreement with Digilab, Inc.
http://www.hd-innovation.com/en/presse/?id=652
2012-01-11European Commission authorizes EU-wide marketing and distribution of Biofrontera's Ameluz
http://www.hd-innovation.com/en/presse/?id=651
2011-12-16Cenix BioScience, CYTOO and academic collaborators Bioquant, EPFL and FTMC receive a 4M€ EU FP7 grant to launch MEHTRICS consortium
http://www.hd-innovation.com/en/presse/?id=647
2011-12-12Biofrontera AG emits new partial debentures of its 5% option bond 2011/2016
http://www.hd-innovation.com/en/presse/?id=644
2011-12-07Cellzome awarded UK's Technology Strategy Board grant as part of the Regenerative Medicine Programme
http://www.hd-innovation.com/en/presse/?id=646
2011-12-06Cellzome Founder wins EU Women Innovators Award
http://www.hd-innovation.com/en/presse/?id=645
2011-12-05